Sila Realty Trust

Sila Realty reported diluted earnings per share of $0.09 for Q4 2025, missing analyst expectations, while revenue of $50.7 million was slightly above forecasts. FFO was $29.8 million ($0.54 per share) and Core FFO was $31.1 million, with a conservative payout ratio around 71–74%. Despite higher interest expenses and earnings pressure, Sila invested $148.9 million in six healthcare properties; the portfolio now comprises 140 assets with 98.7% occupancy and solid tenant quality. The balance sheet remains relatively conservative with net debt of $643.7 million, liquidity of $481.3 million and covenants comfortably met; analyst targets range between $25 and $35. » More on de.investing.com

Sila Realty Trust reported Q4 EPS of $0.09, missing the consensus estimate of $0.17 by 47.06%, while revenue of $50.7 million slightly exceeded the $50.18 million forecast. Despite the earnings disappointment, the stock rose 1.37% to $25.51; cash-NOI for 2025 was $169.9 million and FFO per share increased 3.6% in 2025 to $2.16. Management emphasizes strategic acquisitions and renovations to enhance value and expects rising EPS in upcoming quarters ($0.21 for Q2 2026, $0.22 for Q3 2026), but sees risks from higher interest expenses and tenant turnover. » More on de.investing.com

Sila Realty Trust A will release results for the quarter ended 31 December 2025 on 24 February 2026. One analyst expects earnings per share of $0.170 (prior year $0.200). Three analysts forecast revenue to rise by an average of 7.26% to $49.9 million (prior year $46.6 million). For the most recently completed fiscal year, analysts see annual earnings of $0.680 per share and average annual revenue of $196.6 million. » More on finanzen.net

Sila Realty Trust has acquired a 53,100 sq ft inpatient rehabilitation clinic in Oklahoma City for $43.1 million. The property, opened in 2022, was most recently expanded (plus 18 beds) and is fully leased to the Oklahoma City Rehabilitation Hospital (a subsidiary of Nobis Rehabilitation Holdings) under a long-term absolute-net lease. The acquisition strengthens Sila's healthcare portfolio; the company has high liquidity and a dividend yield of 6.64%. » More on de.investing.com

Sila Realty Trust’s stock fell to a new 52-week low of $22.51 and is down about 12.06% year to date. Investors receive a dividend yield of 6.99%; the stock has a low beta of 0.12 and a price-to-book ratio of 0.92. In Q3 Sila beat consensus estimates with EPS of $0.21 (expectation $0.20) and revenue of $49.85 million (expectation $48.33 million); in premarket trading the stock showed a slight recovery. » More on de.investing.com